Brooke Mitchell

Ms. Brooke Mitchell

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2022 in Viruses
Verified
Journal Article
Open access
PDF file
JPJessica Plante
Jessica Plante
RMRafael Rahal Guaragna Machado
Rafael Rahal Guaragna Machado
BMBrooke Mitchell
Brooke Mitchell
DSDivya Pratik Shinde
Divya Pratik Shinde
JWJordyn Walker
Jordyn Walker
SWScott Weaver
Scott Weaver
The Delta variant of SARS-CoV-2 has caused many breakthrough infections in fully vaccinated individuals. While vaccine status did not generally impact the number of viral RNA genome copies in nasopharyngeal swabs of breakthrough patients, as measured by Ct values, it has been previously found to decrease the infectious viral load in symptomatic patients. We quantified the viral RNA, infectious virus, and anti-spike IgA in nasopharyngeal swabs collected from individuals asymptomatically infected with the Delta variant of SARS-CoV-2. Vaccination decreased the infectious viral load, but not the amount of viral RNA. Furthermore, vaccinees with asymptomatic infections had significantly higher levels of anti-spike IgA in their nasal secretions compared to unvaccinated individuals with asymptomatic infections. Thus, vaccination may decrease the transmission risk of Delta, and perhaps other variants, despite not affecting the amount of viral RNA measured in nasopharyngeal swabs.

23 February 2022 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
MNMarisa Nielsen
Marisa Nielsen
RMRafael Rahal Guaragna Machado
Rafael Rahal Guaragna Machado
BMBrooke Mitchell
Brooke Mitchell
AMAllan J. McConnell
Allan J. McConnell
NSNehad I. Saada
Nehad I. Saada
PRPing Ren
Ping Ren

5 October 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
RRRachel A Reyna
Rachel A Reyna
JWJordyn Walker
Jordyn Walker
BMBrooke Mitchell
Brooke Mitchell
DSDivya Pratik Shinde
Divya Pratik Shinde
JPJessica Plante
Jessica Plante
KPKenneth S Plante
Kenneth S Plante
Anosmia, a total or partial loss of the ability to smell, is one of the most frequently documented sequelae of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Persistent anosmia is associated with a decrease in quality of life. Here, we assess the impact of virus lineage and vaccination status on anosmia development in the golden Syrian hamster model. To characterize anosmia driven by current variants, we assessed olfactory function in hamsters infected with SARS-CoV-2 lineages A, BA.2, BA.5, BQ.1, and BQ.1.1 using a buried food detection test. We found that significant anosmia occurs upon infection with all variants with a significant correlation between disease severity and degree of anosmia. Moreover, we found that vaccination with either the Pfizer (BNT16b2) or Moderna (mRNA-1273) mRNA vaccines does not protect against anosmia, despite protection against severe disease.

24 May 2024 in Viruses
Verified
Journal Article
Open access
PDF file
DSDivya Pratik Shinde
Divya Pratik Shinde
JWJordyn Walker
Jordyn Walker
RRRachel A Reyna
Rachel A Reyna
DSDionna Scharton
Dionna Scharton
BMBrooke Mitchell
Brooke Mitchell
SWScott Weaver
Scott Weaver
The complete lack of yellow fever virus (YFV) in Asia, and the lack of urban YFV transmission in South America, despite the abundance of the peridomestic mosquito vector Aedes (Stegomyia.) aegypti is an enigma. An immunologically naïve population of over 2 billion resides in Asia, with most regions infested with the urban YF vector. One hypothesis for the lack of Asian YF, and absence of urban YF in the Americas for over 80 years, is that prior immunity to related flaviviruses like dengue (DENV) or Zika virus (ZIKV) modulates YFV infection and transmission dynamics. Here we utilized an interferon α/β receptor knock-out mouse model to determine the role of pre-existing dengue-2 (DENV-2) and Zika virus (ZIKV) immunity in YF virus infection, and to determine mechanisms of cross-protection. We utilized African and Brazilian YF strains and found that DENV-2 and ZIKV immunity significantly suppresses YFV viremia in mice, but may or may not protect relative to disease outcomes. Cross-protection appears to be mediated mainly by humoral immune responses. These studies underscore the importance of re-assessing the risks associated with YF outbreak while accounting for prior immunity from flaviviruses that are endemic.

30 May 2022 in medRxiv
Verified
Preprint
Open access
PDF file
DSDaniele M. Swetnam
Daniele M. Swetnam
RAR. Elias. Alvarado
R. Elias. Alvarado
SSStephanea Sotcheff
Stephanea Sotcheff
BMBrooke Mitchell
Brooke Mitchell
AMAllan McConnell
Allan McConnell
ARAndrew Routh
Andrew Routh
SARS-CoV-2 is the etiological agent responsible for the COVID-19 pandemic. It is estimated that only 10 aerosol-borne virus particles are sufficient to establish a secondary infection with SARS-CoV-2. However, the dispersal pattern of SARS-CoV-2 is highly variable and only 10– 20% of cases are responsible for up 80% of secondary infections. The heterogeneous nature of SARS-CoV-2 transmission suggests that super-spreader events play an important role in viral transmission. Super-spreader events occur when a single person is responsible for an unusually high number of secondary infections due to a combination of biological, environmental, and/or behavioral factors. While super-spreader events have been identified as a significant factor driving SARS-CoV-2 transmission, epidemiologic studies have consistently shown that education settings do not play a major role in community transmission. However, an outbreak of SARS-CoV-2 was recently reported among 186 children (aged 10-17) and adults (aged 18 +) after attending an overnight summer camp in Texas in June 2021. To understand the transmission dynamics of the outbreak, RNA was isolated from 36 nasopharyngeal swabs collected from patients that attended the camp and 19 control patients with no known connection to the outbreak. Genome sequencing on the Oxford Nanopore platform was performed using the ARTIC approaches for library preparation and bioinformatic analysis. SARS-CoV-2 amplicons were produced from all RNA samples and >70% of the viral genome was successfully reconstructed with >10X coverage for 46 samples. Phylogenetic methods were used to estimate the transmission history and suggested that the outbreak was the result of a single introduction. We also found evidence for secondary transmission from campers to the community. Together, these findings demonstrate that super-spreader events may occur during large gatherings of children.